Screener
Regeneron Pharmaceuticals REGN Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $2.47B+22.3% | $2.97B-4.0% | $3.12B+25.5% | $2.51B+24.9% | $2.02B+4.5% | ||
| $5.54B+1.2% | $5.79B+10.1% | $5.49B-15.9% | $5.94B-23.7% | $5.47B-30.6% | ||
| $6.57B+17.0% | $5.73B+3.1% | $5.74B-7.6% | $5.69B-6.9% | $5.61B-1.9% | ||
| $3.08B-3.8% | $3.1B-2.8% | $3.2B+3.7% | $3.25B+7.8% | $3.21B+11.6% | ||
| $18.45B+9.4% | $18.21B+3.6% | $18.02B-3.4% | $17.98B-7.0% | $16.86B-11.6% | ||
| $5.46B— | —— | $5.12B— | —— | —— | ||
| $1.31B— | —— | $1.26B— | —— | —— | ||
| $177.9M— | —— | $34.3M— | —— | —— | ||
| $41.73B+9.2% | $40.87B+8.9% | $40.56B+7.4% | $40.17B+7.3% | $38.22B+5.9% | ||
| $1.16B+60.1% | $1.03B+45.6% | $939M+18.9% | $903.8M+81.7% | $723.9M+28.9% | ||
| $684.8M+42.1% | $636.2M+2.7% | $553M-11.9% | $545.6M-13.0% | $481.9M-17.8% | ||
| $720M— | —— | $0— | —— | —— | ||
| $5.53B+50.8% | $5.11B+43.2% | $4.37B+10.8% | $4.43B+20.9% | $3.67B+4.5% | ||
| $1.99B+0.1% | $1.99B+0.1% | $1.99B+0.1% | $1.99B+0.1% | $1.99B+0.1% | ||
| $10.02B+21.0% | $9.45B+15.8% | $9.3B+10.7% | $9.21B+13.5% | $8.28B+5.1% | ||
| $37.62B+11.7% | $36.42B+12.5% | $35.8B+13.0% | $35.05B+14.0% | $33.68B+14.5% | ||
| $31.71B+5.9% | $31.42B+6.9% | $31.26B+6.5% | $30.96B+5.6% | $29.94B+6.1% | ||
| $41.73B+9.2% | $40.87B+8.9% | $40.56B+7.4% | $40.17B+7.3% | $38.22B+5.9% |
FAQ
- What are Regeneron Pharmaceuticals's total assets?
- Regeneron Pharmaceuticals (REGN) holds $41.7B in total assets, up 9.2% year over year.
- How much debt does Regeneron Pharmaceuticals have?
- Regeneron Pharmaceuticals carries $2.7B in total debt against $31.7B of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Regeneron Pharmaceuticals have?
- Regeneron Pharmaceuticals holds $2.5B in cash and equivalents.
- Can Regeneron Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.34 — current assets exceed current liabilities.
- Where does Regeneron Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Regeneron Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
